Treatment of Upper Extremity Lymphedema following Chemotherapy and Radiation for Head and Neck Cancer
- PMID: 32537336
- PMCID: PMC7253291
- DOI: 10.1097/GOX.0000000000002672
Treatment of Upper Extremity Lymphedema following Chemotherapy and Radiation for Head and Neck Cancer
Abstract
In the industrialized world, the most common cause of secondary lymphedema is iatrogenic. The inciting event is generally a combination of lymph node resection, chemotherapy, and radiation therapy. Although a regional nodal dissection is often the primary risk factor, lymphedema can also result from sentinel node dissections, or as in the case presented without any surgical resection. Here, we present a unique case of upper extremity lymphedema resulting from definitive chemoradiation for squamous cell carcinoma of the head and neck. The patient was treated using a combined approach with a lymphaticovenular anastomosis and a free vascularized inguinal lymph node transfer.
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Conflict of interest statement
Disclosure: The authors have no financial interest to declare in relation to the content of this article. Caroline Szpalski received a WBI - Excellence Travelling Grant.
Figures
References
-
- Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg. 2013;132:1305–1314. - PubMed
Publication types
LinkOut - more resources
Full Text Sources